EP2833864
Lyfjablöndur sem innihalda CCR3 mótlyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.4.2013EP published:
19.12.2018EP application number:
13714618.9
EP translation filed:
21.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
1.4.2033Expiry date:
1.4.2026Next due date:
30.4.2026
Title:
PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
Timeline
Today
2.4.2013EP application
19.12.2018EP Publication
21.1.2019Translation submitted
15.2.2019Registration published
1.4.2026Expires
Owner
Name:
Alkahest, Inc.Address:
125 Shoreway Road, Suite D, 94070, San Carlos, CA, US
Inventor
Name:
FETSCHER, AlfredAddress:
Ingelheim Am Rhein, DE
Name:
SCHER, Jochen MatthiasAddress:
Ingelheim Am Rhein, DE
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
12163078Date:
4.4.2012Country:
EP
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/4545, A61P 29/00, A61K 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.4.2019
Expires: 1.4.2020
Payer: Guðjón Styrkársson, hrl.
Number: 8
Paid: 27.4.2020
Expires: 1.4.2021
Payer: Patice ehf.
Number: 9
Paid: 19.4.2021
Expires: 1.4.2022
Payer: Patice ehf.
Number: 10
Paid: 13.4.2022
Expires: 1.4.2023
Payer: Patice ehf.
Number: 11
Paid: 22.4.2023
Expires: 1.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.4.2024
Expires: 1.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.4.2025
Expires: 1.4.2026
Payer: Árnason Faktor ehf.